Clinical efficacy of ribociclib as a first-line therapy for HR-positive, advanced breast cancer.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Carmen Criscitiello Giuseppe Curigliano Luca Mazzarella |
| Publication date | January 22, 2018 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |